THEMIS MEDICARE Financial Statement Analysis
|
||
|
The Revenues of THEMIS MEDICARE have increased by 71.07% YoY .
The Earnings Per Share (EPS) of THEMIS MEDICARE has decreased by -21.95 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
THEMIS MEDICARE Last 5 Annual Financial Results
[BOM: 530199|NSE : THEMISMED]
| Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹395 Cr | ₹231 Cr | ₹202 Cr | ₹184 Cr | ₹210 Cr |
| Expenses | ₹299 Cr | ₹181 Cr | ₹166 Cr | ₹181 Cr | ₹185 Cr |
| Operating Profit (Excl OI) | ₹96 Cr | ₹49 Cr | ₹36 Cr | ₹2.28 Cr | ₹25 Cr |
| Other Income | ₹6.54 Cr | ₹3.62 Cr | ₹3.47 Cr | ₹2.67 Cr | ₹3.49 Cr |
| Interest | ₹8.78 Cr | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr |
| Depreciation | ₹9.48 Cr | ₹8.55 Cr | ₹8.27 Cr | ₹7.99 Cr | ₹7.42 Cr |
| Profit Before Tax | ₹95 Cr | ₹32 Cr | ₹18 Cr | ₹-15 Cr | ₹8.74 Cr |
| Profit After Tax | ₹73 Cr | ₹26 Cr | ₹16 Cr | ₹-13 Cr | ₹8.64 Cr |
| Consolidated Net Profit | ₹73 Cr | ₹36 Cr | ₹25 Cr | ₹-11 Cr | ₹11 Cr |
| Earnings Per Share (Rs) | ₹61.83 | ₹79.22 | ₹38.86 | ₹26.97 | ₹-11.70 |
| PAT Margin (%) | 16.06 | 18.47 | 11.37 | 7.88 | -7.09 |
| ROE(%) | 18.16 | 28.84 | 13.09 | 9.34 | -8.00 |
| ROCE(%) | 20.59 | 31.07 | 15.21 | 11.81 | -1.25 |
| Total Debt/Equity(x) | 0.27 | 0.27 | 0.39 | 0.54 | 0.52 |
Key Financials |
||
| Market Cap | : | ₹ 1,990.0 Cr |
| Revenue (TTM) | : | ₹ 364.0 Cr |
| Net Profit(TTM) | : | ₹ 27.7 Cr |
| EPS (TTM) | : | ₹ 3.0 |
| P/E (TTM) | : | 71.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| THEMIS MEDICARE | 4.3% | -1.4% | 43.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
| CIPLA | 4.1% | -4.8% | 55.6% |
| DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
| ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
| DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
| MANKIND PHARMA | 1.3% | 7% | NA |
| TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
| LUPIN | 0.6% | 0.5% | 127.2% |
THEMIS MEDICARE Revenues
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | 71.07 % |
| 5 Yr CAGR | 17.15 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹395 Cr | 71.07 | |
| Mar2022 | ₹231 Cr | 14.43 | |
| Mar2021 | ₹202 Cr | 9.70 | |
| Mar2020 | ₹184 Cr | -12.29 | |
| Mar2019 | ₹210 Cr | - | |
THEMIS MEDICARE Operating Profit
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | 93.23 % |
| 5 Yr CAGR | 40.52 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹96 Cr | 93.23 | |
| Mar2022 | ₹49 Cr | 38.81 | |
| Mar2021 | ₹36 Cr | 1,464.59 | |
| Mar2020 | ₹2.28 Cr | -90.71 | |
| Mar2019 | ₹25 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 12.95 % |
| 5 Yr CAGR | 19.95 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 24.24% | 12.95 | |
| Mar2022 | 21.46% | 21.31 | |
| Mar2021 | 17.69% | 1,326.61 | |
| Mar2020 | 1.24% | -89.41 | |
| Mar2019 | 11.71% | - | |
THEMIS MEDICARE Profit After Tax
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | 104.13 % |
| 5 Yr CAGR | 59.39 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹73 Cr | 104.13 | |
| Mar2022 | ₹36 Cr | 44.07 | |
| Mar2021 | ₹25 Cr | Positive | |
| Mar2020 | ₹-11 Cr | Negative | |
| Mar2019 | ₹11 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -13.05 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 16.06 % | -13.05 | |
| Mar2022 | 18.47 % | 62.45 | |
| Mar2021 | 11.37 % | 44.29 | |
| Mar2020 | 7.88 % | Positive | |
| Mar2019 | -7.09 % | - | |
THEMIS MEDICARE Earnings Per Share (EPS)
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | -21.95 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹62 | -21.95 | |
| Mar2022 | ₹79 | 103.86 | |
| Mar2021 | ₹39 | 44.09 | |
| Mar2020 | ₹27 | Positive | |
| Mar2019 | ₹-12 | - | |
THEMIS MEDICARE Return on Capital Employed (ROCE)
[BOM: 530199|NSE : THEMISMED]
| Y-o-Y | -33.73 % |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 20.59% | -33.73 | |
| Mar2022 | 31.07% | 104.27 | |
| Mar2021 | 15.21% | 28.79 | |
| Mar2020 | 11.81% | Positive | |
| Mar2019 | -1.25% | - | |
THEMIS MEDICARE Share Price vs Sensex
| Current Share Price | : | ₹216.3 |
| Current MarketCap | : | ₹ 1,990.0 Cr |
| Updated EOD on | : | Apr 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | 4.3% |
-1.4% |
43.1% |
| SENSEX | 0.9% |
1.5% |
23.6% |
THEMIS MEDICARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE MIDSMALLCAP | 4% | 9.7% | 67.3% |
| S&P BSE SMALL CAP | 4% | 11.6% | 67.3% |
| S&P BSE HEALTHCARE | 3% | 4% | 55.2% |
| S&P BSE ALLCAP | 2.3% | 5% | 41.4% |
No NSE index found
You may also like the below Video Courses
FAQ about THEMIS MEDICARE Financials
How the annual revenues of THEMIS MEDICARE have changed ?
The Revenues of THEMIS MEDICARE have increased by 71.07% YoY .
How the Earnings per Share (EPS) of THEMIS MEDICARE have changed?
The Earnings Per Share (EPS) of THEMIS MEDICARE has decreased by -21.95 % YoY .
Check out Intrinsic Value of Peers of THEMIS MEDICARE
Compare Stock Analytics of Peers of THEMIS MEDICARE
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
